top of page






19 August 2022

Atgenomix is Now an HL7 Gold Member

As a Gold Member in Health Level Seven International (HL7), Atgenomix supports the HL7 objective to create a suite of standard-based technologies for streamlining sophisticated data management and computational analysis of biomedical and multi-omics information.

2 August 2022

Atgenomix Presents at Taiwan-Australia Collaboration Forum

Atgenomix CEO, Allen Chang, shared how our BioMed-IT platform can empower biotech and precision medicine industries to innovate at scale and speed.

1 August 2022

Atgenomix Receives Recognition from the 5th Charity Festival of Chinese

CSR2022 華人公益大使 recognizes the contributions of Atgenomix to the field of precision medicine.

16 May 2022

Atgenomix Staff Scientist Joins Virtual Symposium for Dentists

Yin-Hung Lin, Ph.D. presented and discussed how a unified bioinformatics platform can empower the precision medicine industry in the application of digital transformation to face the challenges of paradigm shift in dentistry and medicine, in particular oral cancer genomics.

1 April 2022

The Future of Precision Medicine

Allen joins Science Monthly as a guest contributor, sharing how biomedical information technology drives the future of precision medicine.

19 May 2020

Cloud-based genome analysis could help speed up development of a COVID-19 vaccine

Researchers in Taiwan gain access to a platform that processes genome sequencing data faster than conventional methods.

Collaborative Publications

bottom of page